Q3 2026 Cardinal Health Inc Earnings Call Transcript
Key Points
- Cardinal Health Inc (CAH) reported an 11% increase in total company revenue to $61 billion, driven by strong demand in the Pharmaceutical and Specialty Solutions segment.
- Gross profit grew 18% to $2.5 billion, benefiting from acquisitions and strong segment performance.
- The company raised its full-year fiscal 2026 non-GAAP EPS and adjusted free cash flow guidance, reflecting confidence in continued operational strength.
- Specialty revenue grew over 20% in the third quarter, with expectations to exceed $50 billion in fiscal 2026.
- The integration of acquisitions like Solaris and ADS is progressing well, contributing to robust growth in Specialty and at-Home Solutions businesses.
- The GMPD segment saw a decrease in profit to $25 million due to adverse net impacts of tariffs.
- A $184 million pretax goodwill impairment charge related to the Navista business impacted GAAP earnings.
- The company faces uncertainty regarding the timing, scope, and administration of potential tariff refunds.
- Revenue growth in the Pharma segment was impacted by Inflation Reduction Act WAC pricing adjustments and fluctuations in GLP-1 revenue growth.
- Increased SG&A expenses, up 17% on a headline basis, reflect higher volumes and investments in teams and technology.
Hello, and welcome to the third quarter fiscal year 2026 Cardinal Health Incorporated earnings conference call. My name is George, and I'll be coordinator for today's event. Please note, this conference is being recorded. (Operator Instructions)
I'd like to hand the call over to your host, Mr.
Good morning, and welcome to Cardinal Health's third quarter fiscal '26 earnings conference call, and thank you for joining us. With me today are Cardinal Health's CEO, Jason Hollar; and our CFO, Aaron Alt. You can find this morning's earnings press release and investor presentation on the Investor Relations section of our website at ir.cardinalhealth.com.
Since we will be making forward-looking statements today, let me remind you that the matters addressed in these statements are subject to risks and uncertainties that could cause our actual results to differ materially from those projected or implied. Please refer to our SEC filings and the forward-looking statement slide at the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
